LA-based C3 Jian has raised $30 million to advance its lead peptide treatment into the clinic, testing its ability to re-mineralize teeth. The biotech, which is moving into a new facility, raised the cash from Wyssta Investments, Renaissance Health Services, and Corvesta. It is developing technology discovered at UCLA. Release